Waleed H Hassanein $TMDX SEC Form 4 Insider Trading

Waleed H Hassanein has filed a total of 86 insider trades in $TMDX since 2021. Their most recent trade was a sale of 300 shares, made on Oct 15, 2024. Their largest trade was a sale of 30,000 shares, made on May 06, 2024. We estimate that they now own 61,643 shares of $TMDX, worth an estimated $4.0 million.

Insider Trading at $TMDX

There have been a total of 315 insider trades reported at $TMDX since 2021, with 102,500 shares purchased and 1.3 million shares sold. The most active insider traders in $TMDX stock have been Tamer I Khayal, Waleed H Hassanein, and John F Carey. The most recent trade was a sale of 1,084 shares reported by Tamer I Khayal (Chief Commercial Officer), made on Dec 02, 2024.

$TMDX Executives and Stock Owners with Insider Trades

• Tamer I Khayal, Chief Commercial Officer

• Waleed H Hassanein, President & CEO

• John F Carey, VP of Operations

• Stephen Gordon, Chief Financial Officer

• Miriam Provost, VP, Global Regulatory Affairs

• Laura Damme, VP, Clinical Affairs

• Anil P. Ranganath, See remarks

• Nicholas Corcoran, See Remarks

• Miriam Provost, VP of US Regulatory & FDA Rel.

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.